Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

STRIDES PHARMA SCIENCE LIMITED Call Transcript 2025

Jul 23, 2025

62616_rns_2025-07-23_f643c841-ded3-46b5-82ae-bcd6af89b8ec.pdf

Call Transcript

Open in viewer

Opens in your device viewer

July 23, 2025

BSE Limited Phiroze Jeejeebhoy Towers, Dalal Street, Mumbai – 400 001. National Stock Exchange of India Limited Exchange Plaza, Bandra-Kurla Complex, Bandra (E), Mumbai - 400 051.

Scrip Code: 532531

Scrip Code: STAR

Dear Madam/ Sir,

Sub: Earnings Call to discuss unaudited financial results of the Company for the quarter ended June 30, 2025.

This is to inform you that the Company has scheduled its Earnings Call with analysts/ investors on Tuesday, July 29, 2025, at 16:30 hrs IST to discuss unaudited financial results of the Company for the quarter ended June 30, 2025.

Earnings Call details are enclosed for ready reference.

Further, kindly note that the above information will also be available on the website of the Company i.e., www.strides.com.

This is for your kind information and record.

Thanks & Regards For Strides Pharma Science Limited, Manjula Ramamurthy MANJUL A R Digitally signed by MANJULA R Date: 2025.07.23 19:04:13 +05'30'

Company Secretary & Compliance Officer ICSI Membership No. A30515

Encl: a/a

Strides Pharma Science Limited

invites you to interact with the senior management on Q1FY26 Performance

4:30 pm IST / 12:00 pm BST / 7:00 am EDT / 7:00 pm HKT

Participants from the Management would be:

Arun Kumar

Badree Komandur

Vikesh Kumar

Founder & Non-Executive Chairperson Managing Director & Group CEO

Group CFO

For any query, please reach out to [email protected]